Clinical Trial Update: Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2b imaging study of RAD101 for suspected recurrent brain metastases is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• RAD101

Snippet

Sponsor: Radiopharm Theranostics, Ltd | Conditions: Brain Metastases From Solid Tumors | Phase 2 | Status: RECRUITING